Key Lecture: Entry, occurrence, behavior and effects of pharmaceuticals in the environment

Similar documents
Are Veterinary Medicines Causing Environmental Risks?

Environmental impacts of Veterinary Medicines - State of knowledge, options for improvement

EurEau s Contribution to the European Commission s Strategic Approach on Veterinary Pharmaceuticals in the Environment

Mixtures of veterinary medicinal compounds in manured soils

European Public MRL assessment report (EPMAR)

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

Fate and Transport of Hormones & Antimicrobials

Opinion of the Committee for Medicinal Products for Veterinary Use pursuant to Article 30(3) of Regulation (EC) No 726/2004

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised

AMR in Codex Alimentarius Commission and country responsibilities

UBA and Tukes concerned about the environmental impacts of veterinary medicines

Occurrence and transformation of veterinary pharmaceuticals and biocides in manure: a literature review

SUMMARY OF PRODUCT CHARACTERISTICS

Metacam 1.5 mg/ml oral suspension for dogs

Analysis of Hormones & Anabolics

SUMMARY OF PRODUCT CHARACTERISTICS. 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Emdocam 20 mg/ml solution for injection for cattle, pigs and horses

ManureTracker: On the Trail of Hormones, Antimicrobials and Antimicrobial Resistance Genes

ANTIBIOTICS IN AQUACULTURE: A (FISH) VETERINARIAN S PERSPECTIVE

SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics

Summary of Product Characteristics

Draft agreed by the Environmental Risk Assessment Working Party (ERAWP) 30 April 2018

European public MRL assessment report (EPMAR)

SUMMARY OF PRODUCT CHARACTERISTICS. NUFLOR 300 mg/ml solution for injection for cattle and sheep

Summary of Product Characteristics

MARBOCYL 10% SUMMARY OF PRODUCT CHARACTERISTICS

Human Food Safety of Veterinary Drugs. Bettye K. Walters, DVM

Validation of bee4sensor for Honey

Diclofenac in Europe an update

Deborah A. Cera - Division of Compliance Center for Veterinary Medicine, FDA

Recommended for Implementation at Step 7 of the VICH Process on 15 December 2004 by the VICH Steering Committee

Methods development to detect antibiotic activity in water samples

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/12

Occurrence, fate, and ecotoxicity of antibiotics in agro-ecosystems. A review

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP) REVISED GUIDELINE ON THE SPC FOR ANTIMICROBIAL PRODUCTS

Devil s Claw a natural substitute for diclofenac?

Antibiotic Residues in Animal Waste: Occurrence and Degradation in Conventional Agricultural Waste Management Practices

SUMMARY OF PRODUCT CHARACTERISTICS

Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate

Principles of Antimicrobial therapy

Antibiotic Residues in Meat and Meat Products, Implications on Human Health

SUMMARY OF PRODUCT CHARACTERISTICS

LEVOFLOXACIN RESIDUES IN CHICKEN MEAT AND GIBLETS

Antibiotics in Dust Originating from a Pig-Fattening Farm: A New Source of Health Hazard for Farmers?

What is antimicrobial resistance?

A Unique Approach to Managing the Problem of Antibiotic Resistance

Summary of Product Characteristics

Summary of Product Characteristics

Potential Impacts of Antibiotics in the Environment

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

مادة االدوية المرحلة الثالثة م. غدير حاتم محمد

Human health impacts of antibiotic use in animal agriculture

For the treatment and prevention of infections caused by:

Pharm 262: Antibiotics. 1 Pharmaceutical Microbiology II DR. C. AGYARE

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS. Vetmulin 450 mg/g granules for use in drinking water for pigs. (All MS except FR)

SUMMARY OF PRODUCT CHARACTERISTICS. Equest Oral Gel, 18,92 mg/g, Oral Gel for Horses and Ponies

SUMMARY OF PRODUCT CHARACTERISTICS. Bottle of powder: Active substance: ceftiofur sodium mg equivalent to ceftiofur...

Residues. Mike Apley, DVM, PhD

INTRODUCTION TO WILDLIFE PHARMACOLOGY. Lisa Fosco Wildlife Rehabilitation Manager Toronto Wildlife Centre

International Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-2, 2017, 1-7 Research Article Open Access.

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

Beef Producers. The Judicious Use of Antimicrobials for

SUMMARY OF PRODUCT CHARACTERISTICS. Cephacare flavour 50 mg tablets for cats and dogs. Excipients: For a full list of excipients, see section 6.1.

Proceedings of the 13th International Congress of the World Equine Veterinary Association WEVA

Global Food Supply Chain Risks. Antibiotics and the emergence of antibiotic-resistant bacteria in the food chain

Amoxicillin trihydrate and potassium clavulanate. Amoxicillin trihydrate and potassium clavulanate. Amoxicillin trihydrate and potassium clavulanate

Scientific Discussion post-authorisation update for Rheumocam extension X/007

Sheep Scab. Fig. 1: Sheep scab can be introduced from stray sheep - this perimeter fence is not secure.

SELECT NEWS. Florfenicol Monograph: Injectable Therapy for Cattle

Antibiotic resistance and the environment there and back again

Status of Vultures in India

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

USA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION

Responsible Use of Veterinary Products. Bettye K. Walters, DVM

Reprinted in the IVIS website with the permission of the meeting organizers

Chapter 2 Residual Veterinary Pharmaceuticals in Animal Manures and Their Environmental Behaviors in Soils

Agriculture & Agri-Food Canada, Research Centre, Lethbridge, AB. Environment Canada, Saskatoon, Saskatchewan

Herbal Medicine for Animal Use in JAPAN

SUMMARY OF PRODUCT CHARACTERISTICS

Changing Practices to Reduce Antibiotic Resistance

Summary of Product Characteristics

SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics

Multi-residue Method II for Veterinary Drugs by HPLC (Animal and Fishery Products)

AMR dissemination in the environment Professor Liz Wellington

Parasite Prevention Strategies for Bison.

Quality Services International GmbH. Testreport. Czech Honey Prokes Blanka M. Lukes Hajni 1363 CZ Prague Czech Republic

Country Report: Malaysia

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANTIMICROBIAL USAGE IN AQUACULTURE

SUMMARY OF PRODUCT CHARACTERISTICS

Strength Animal species Recommended dose. Member State Applicant Invented name Pharmaceutical form

Antibiotic Resistance Genes and their Association in Dairy Cattle

Veterinary Feed Directive Information

Medically Important Antibiotics in Animal Agriculture

Transcription:

Workshop Pharmaceuticals in Soil, Sludge and Slurry (Dessau, 18 th June to 19 th June 2013) Key Lecture: Entry, occurrence, behavior and effects of pharmaceuticals in the environment Gerd Hamscher Faculty Biology and Chemistry Institute of Food Chemistry and Food Biotechnology

Contents Introduction Effects and risks of veterinary drugs Challenges for food safety Strategies for reduction Conclusions / Summary

Introduction Application of veterinary drugs in livestock farming Antibiotics (most important class in UK, Denmark, The etherlands, USA, China, Germany) Endectocides (e. g. ivermectin) Coccidiostats (e. g. nicarbazin) Antifungals (e. g. chlorhexidine)

Introduction Application of veterinary drugs in livestock farming Veterinary drugs (administration i. v., i. m., via drinking water or feed) Therapy Prophylaxis (forbidden in Germany) Metaphylaxis Feed additives ( Growth promoters ) EU ban on this special use since 01.0.1.2006 Frequently used in USA, Asia

Use of veterinary antibiotics in Europe (Grave et al. 2010) Germany: 1734 tons of antibiotics (BVL, 2012)

Frequently used veterinary drugs CH 3 Cl H CH 3 H (CH 3 ) 2 H H CH 3 H H (CH 3 ) 2 H H 3 C H 2 C H H H H Chlortetracycline CH 2 H H H xytetracycline CH 2 H CH 3 CH 3 CH 3 H 2 C CH 3 H CH 3 H H 3 C H CH 3 (CH 3 ) 2 H H CH 3 H (CH 3 ) 2 H H HH S CH 3 CH 3 Tylosin H H H CH 2 CH 3 CH Tetracycline Benzylpenicilline S S Various substance classes H 2 H H 2 H Complex Matrices Sulfadiazine Sulfamethazine Method of choice: LC/MS/MS

Entry and exposure routes for pharmaceuticals Application of Pharmaceuticals Veterinary Medicine Human Medicine Livestock Farming Aquaculture Domestic Animals Sewage Treatment Plant Fermentor Manure (up to 260 mg/kg) Direct environment Sewage Sludge Agricultural Land (up to 0,5 mg/kg) Plants (~10-50 µg/kg) (Stable-)Dust from feed and dried manure (~mg/kg) Excreta, Saliva, Hair,?? Groundwater (~0,1 µg/l) Surface Water (µg/l) Drinking Water (~10 ng/l) Exposition of Humans (Hamscher and Mohring, 2012)

Fate of antibiotics after application Most antibiotics (e. g. tetracycline, macrolids) are only poorly metabolised after administration -acetyl-sulfonamides are de-acetylated to the parent compound in manure ccurrence of a cocktail of persistant antibiotics (e.g. various tetracyclines and sulfonamides) in liquid manure in concentrations up to several 100 mg/kg Hot spots of tetracyclines in dried liquid manure soil aggregates with concentrations up to 1.5 mg/kg (Langhammer et al. 1988, Winckler et al. 2000, Hamscher et al. 2002, Engels 2004, Boxall 2008)

Fate of pharmaceuticals in soil Sorption, transport and degradation processes may occur Many interacting factors influence the fate of veterinary drugs in soil: Hydrophobic properties, ion exchange, cation bridging at clay surfaces, surface complexation, hydrogen bonding Water solubility, ph value, moisture content, temperature, timing of manure application Problem: wide variety of soil types, behaviour of drugs in the soil-liquid manure matrix early impossible to predict accurately the environmental fate of a certain drug (Tolls 2001, Thiele-Bruhn 2003, Schauss et al. 2009)

Contents Introduction Effects and risks of veterinary drugs Challenges for food safety Strategies for reduction Conclusions / Summary

Effects of veterinary antibiotics Remind: microorganisms are the targets of antibiotics in nature and in medicine Manure, marine sediments and dried manured soil aggregates: concentrations within the minimally inhibitory concentration (0.5 2 mg/l) for various bacteria Manure: reservoir of resistant bacteria and antibiotics Application to agriculturall soils increases antibiotic resistance genes and the selection of resistant soil bacteria Changes in microbial communities Is there a risk for human exposure to soil-borne resistance? (Schmitt et al. 2006, Heuer et al. 2010)

Veterinary endectocides Ivermectin / Moxidectin 1980s: fermentation of soil-derived microbes led to the identification of macrocyclic lactones with strong activity against ectoparasites and endoparasites (endectocides) Frequent worldwide use in veterinary medicine and agriculture Macrocyclic lactones are substances of high concern regarding environmental aspects Various environmental consequences on non-target organisms are reported

Veterinary endectocides Ivermectin / Moxidectin Exposure to ivermectin via dung from treated animals leads to Reduction in growth rate of various dung-inhabiting insects (Wall and Strong, ature 1987) Increase in adult and larval mortality Alternative: repeated treatment with injectable formulations Replacement of ivermectin by moxidectin Moxidectin less toxic for dung breeding insects on-target species toxicity: more toxic for fish than ivermectin

Veterinary cytostatics H P Cl Cl Cyclophosphamide (CPP) M = 261,1 g/mol H H 3 CC H CH 3 H Vinblastine (VIB) M = 811 g/mol CH 3 H 3 C H H H 3 C H H H Doxorubicin (DXR) M = 544 g/mol H 2 H 3 C H H 3 CC H 3 C H H H CH 3 CH 3 H H H CCH 3 CCH 3 CCH 3 CH 3 CCH 3 Vincristine (VIC) M = 825 g/mol Domestic animals getting older (nutrition / medical diagnostics) Desire of the owner for best medical treatment: chemotherapy (Mohring 2011)

Veterinary cytostatics Environment/ surroundings Dog serum Hospital staff Blood withdrawal and handling in the lab Dog urine injuries Dog saliva Removal of urine at home licking Patient owner / Persons in the near surrounding Change Dog hair Is there a risk for the environment/humans in the near surrounding through urine, serum, saliva or hair of treated animals (Mohring 2011)

Veterinary cytostatics Risk assessment and outlook Highest risk results from dog urine Low risk for hospital staff through contact with serum Considerably lower risk through contact with saliva and hair Doxorubicin: substance with the most probable risk excretion up to 21 days with urine Adaption of international guidelines (e.g. ECVIMCA) Handout/Suggestions for patient owners (Hamscher et al. 2010, Knobloch et al. 2010, Mohring 2011)

Dramatic adverse environmental effect of diclofenac 2005: Catastrophic decline (> 95 %) of three vultures species in southeast Asia due to diclofenac poisoning (lethale dose: 0,1 0,2 mg/kg, < 1 mg / bird) Diclofenac: on-steroidal anti-inflammatory drug (SAID) Picture: http://www.organische-chemie.ch/chemie/2010/sep/diclofenac.shtm

Dramatic adverse environmental effect of diclofenac Acute kidney failure Large urate deposits on internal organs Death within a few days Diclofenac residues in animal carcasses of cows and domestic goats ne large meal responsible for rapid death of three Gyps vultures, which showed extreme sensitivity to this drug Cows were treated within a day or two before death (Green et al. 2006) Comparable sensitivity in two other vultures species (Gyps africanus and the Eurasian griffon vulture, Gyps fulvus; Swan et al. 2006)

Contents Introduction Effects and risks of veterinary drugs Challenges for food safety Strategies for reduction Conclusions / Summary

2012 Field and lysimeter studies 2000 2012 Tetracyclines? Sulfonamides?? Tetracyclines >500 µg/kg) Sulfonamides <2 µg/kg Substantial amounts of antibiotics occur in liquid manure, in soil and in dust (mg/kg) Strong sorption in soil may reduce bioavailibility but also degradation Sulfonamides are reaching our groundwater resources TCs: n.n. SA: n.n. Dust may also contribute to the spread of antibiotics and antibiotic resistance Sulfonamides 0,24 µg/l Tetracyclines 0,13 µg/l (Hamscher et al. 2002, 2003, 2005, 2008 and current investigations)

Mineral water Legal aspects (Germany, AVV Anl. 1a ) atural pure mineral water (Drugs)

µg/ml urine Carry-ver of sulfamethazine 100 mg/kg oral via feed, 5 days of treatment 60 Treatment 50 40 30 20 10 0 1 2 3 4 5 6 7 8 9 10 day (Kietzmann et al. 1995)

µg/ml urine Carry-ver of sulfamethazine 10 8 o treatment, but animals were housed in boxes of treated animals* on day 5 6 4 2 0 < LD 0 1 2 3 4 5 6 7 8 9 10 day *100 mg/kg oral via feed, 5 days of treatment (Kietzmann et al. 1995)

Contents Introduction Effects and risks of veterinary drugs Challenges for food safety Strategies for reduction Conclusions / Summary

The 3R-concept

Replacement of veterinary drugs Pitfalls Environmentally friendly drugs may be less active In the case of antibiotics and endectocides: limitation to a small number of compounds may result in an increase in the development of resistant strains ew and unexpected risks for non-target organisms

Replacement of diclofenac by meloxicam 2006: Ban of diclofenac in veterinary medicine in India, Pakistan and epal Diclofenac was replaced by the SAID meloxicam Toxicology and pharmacology of meloxicam (Cuthbert et al. 2007): o association with any toxicity in birds Investigations in > 60 species without any obvious adverse effects Studies in different vulture species demonstrated a short half-life of elimination, accumulation of the drug unlikely Productivity of Indian vultures (G. indicus) in southeast Pakistan and in some Indian states has increased

Developing environmentally sound sulfonamides Lysimeter studies Risk of groundwater contamination All compounds in one cocktail Drug formulation Granulation, microencapsulation, nanoparticles Higher plasma levels lower dosing Ranking of compounds and QSAR Identification of structural properties Recommendations for veterinarians Synthesis of new compounds Photooxidation studies Aquaculture: rapid degradation important Toxicity / antimicrobial activity testing Anaerobic fermentation Single compound testing Toxicity / antimicrobial activity testing Identification of degradation products

General remarks What does environmentally sound imply? After therapeutic use, a drug is metabolized or transformed to a biologically inactive or non-toxic product (= elimination) In the case of antibiotics: loss of antimicrobial activity Consequences for research: The non-toxicity and / or loss of biological / antimicrobial activity has to be demonstrated Degradation products have to be identified and characterised

Conc. [µg/kg] Anaerobic fermentation of various sulfonamides 3000 Start day 8 day 14 day 21 day 28 day 34 CH 3 R Sulfadiazine Sulfathiazole Sulfamerazine Sulfamethazine SDZ STZ SMR SMZ 2000 CH 3 Sulfamethoxypyridazine SMPD 1000 S CH 3 CH 3 CH 3 CH 3 Sulfamethoxazole Sulfadimethoxine SMX SDM 0 CH 3 SDZ STZ SMR SMZ SMPD SMX SDM TMP (Mohring et al. 2009)

Konz. [µg/kg] Relative Intensity [%] Identification of the metabolite (4-H-SDZ) 100 50 A MS/MS 174 112 +2H H 2 S H 70 156 H B 70 112 50 100 115 70 C Isocytosine MS 3 +H H 2 H 112 H 2 S H H 0 92 156 50 100 115 m/z 174 92 108112 [M+H] + 267 80 100 150 250 270 m/z (Mohring et al. 2009) 500 400 What about the antimicrobial activity? Half-quantitative detection of the metabolite 300 200 100 0

Microbial inhibition testing 4-H-SDZ SDZ antimicrobial activity < 10 % (Mohring et al. 2009)

Conclusions / Summary There are still a lot of open questions Do we really know all routes of entry for veterinary drugs into the environment? Is it really possible to identify and / or synthesise environmentally sound pharmaceuticals without the loss of therapeutic efficacy? meanwhile: reduce the entry Healthy animals need less treatment Prudent use of antibiotics Fermentation or (??) of liquid manure Knowledge transfer to veterinarians, farmers, students and consumers

Acknowledgement I am grateful to my collegues and co-workers Heinrich Höper (LBEG), Jörg Kues (ex LfB), Siegrun Mohring (JLU), Heinz au (ex TiHo), Heike Pawelzick (ex TiHo), Anja Platt (JLU), Beate Prieß (TiHo), Marion Schröder (ex TiHo), Silke Sczesny (ex TiHo), Dr. Astrid Spielmeyer (JLU) ur research was funded by the following institutions Thank you for your attention!!!